Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

BACKGROUND: Hypoxia can reduce the levels of soluble receptor for advanced glycation end-products (sRAGE), a new anti-inflammatory biomarker of COPD. We assessed sRAGE in patients with hypoxia-related diseases such as COPD, OSA and OSA-COPD overlap. METHODS: Plasma levels of sRAGE were measured in 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin-Oto, Marta, Sanz-Rubio, David, Santamaría-Martos, Fernando, Benitez, Ivan, Simon, Ana L., Forner, Marta, Cubero, Pablo, Gil, Ana, Sanchez-de-laTorre, Manuel, Barbe, Ferran, Marin, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210762/
https://www.ncbi.nlm.nih.gov/pubmed/35729539
http://dx.doi.org/10.1186/s12931-022-02092-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210762/
https://www.ncbi.nlm.nih.gov/pubmed/35729539
http://dx.doi.org/10.1186/s12931-022-02092-9

Ejemplares similares